本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Alterity Therapeutics Limited

4.66
+0.37008.62%
盘后4.53-0.1300-2.79%18:14 EDT
成交量:12.79万
成交额:58.41万
市值:8,446.57万
市盈率:-6.24
高:4.88
开:4.25
低:4.15
收:4.29
52周最高:7.00
52周最低:1.00
股本:1,812.57万
流通股本:1,245.82万
量比:0.14
换手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-0.7470
每股收益(LYR):-0.7470
净资产收益率:-43.23%
总资产收益率:-28.09%
市净率:3.06
市盈率(LYR):-6.24

数据加载中...

2019/09/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/17

SEC问询函

[Cover]Correspondence
2019/05/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]